Aurora Kinase: A Target for Cancer Therapy

Authors

  • Pushpaveni C T John College of Pharmacy
  • Arun Kumar C.
  • Visagaperumal D.
  • Vineeth Chandy

Abstract

Aurora kinases are the enzymes that belong to the family of serine/threonine kinases. It consists of Aurora-A (AURK-A), Aurora-B (AURK-B) and Aurora-C (AURK-C), which are the essential kinases for cell division through mitosis regulation especially for the process of chromosomal segregation. Aurora kinases are involved in meiosis regulation along with the regulation of mitosis. Inhibition of Aurora kinase leads to neglected cell division. Various cancer studies generally deal with gene amplification or overexpression. From the literature review, it is clear that inhibiting Aurora kinase will increase the effect of chemotherapies. Hence from the past decades, Aurora kinase inhibitors were developed, and they are now in clinical trials; however, these inhibitors effectively fail to give the complete therapy for cancer. This review mainly focuses on the Aurora kinase inhibitors and Aurora kinase as a target for anticancer therapy.

 

Keywords: Aurora-A, Aurora-B, Aurora-C, Aurora kinases, Aurora kinases inhibitors, cancer therapy target, mitosis

 

Cite this Article

Pushpaveni C., Arun Kumar C., Visagaperumal D., Vineeth Chandy. Aurora Kinase: A Target for Cancer Therapy. Research & Reviews: A Journal of Pharmacology. 2019; 9(3): 10–17p.

Downloads

Published

2020-01-06

Issue

Vol. 9 No. 3 (2019)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.